News Overview
Evestra out-licenses marketing rights for near-term product for Russia and CIS territories
Evestra out-licenses rest-of-the-world (ROW) marketing rights for near-term product
Evestra signs second R&D collaboration with RCPE, Graz to develop proprietary vaginal drug delivery technology
Evestra closes private offering raising $2.5 million
Evestra out-licenses European marketing rights for near-term product
Evestra receives a new contract from NIH to manufacture cGMP grade hormonal steroid
Evestra's second US patent issued
November 30
October 18
June 7
July 23
July 17
May 30
May 14
2012
For more 2012 info, please click here.
© 2017 Evestra, Inc.
